| 5.29 Data as of May 23 |  -0.01 / -0.19%Today’s Change | 3.76 Today|||52-Week Range 7.44 | -17.73% Year-to-Date |
| Why Accuray's Earnings May Be Less Than Awesome May 17 / MotleyFool.com | Are the Earnings at Accuray Hiding Something? May 16 / MotleyFool.com |
| Previous close | 5.30 |
| Today’s open | 5.25 |
| Day’s range | 5.24 - 5.42 |
| Volume | 1,028,493 |
| Average volume (3 months) | 1,056,687 |
| Market cap | $392.8M |
| Dividend yield | -- |
| Earnings growth (last year) | -131.82% |
| Earnings growth (this year) | -83.54% |
| Earnings growth (next 5 years) | +72.00% |
| Revenue growth (last year) | +84.10% |
| P/E ratio | NM |
| Price/Sales | 1.18 |
| Price/Book | 1.95 |
| Today’s change | Today’s % change | |
|---|---|---|
| CYNOCynosure Inc | +1.06 | +4.42% |
| IVCInvacare Corp | +0.47 | +3.30% |
| TEARTearLab Corp | +0.73 | +7.64% |
| IMMUImmunomedics Inc | +0.14 | +4.46% |
| Next reporting date | September 23, 2013 |
| EPS forecast (this quarter) | -$0.21 |
| Annual revenue (last year) | $409.2M |
| Annual profit (last year) | -$72.0M |
| Net profit margin | -17.60% |
Sector Health Technology |
Industry Medical Specialties |
President, Chief Executive Officer & Director Joshua H. Levine |
Executive VP-Engineering & Global Operations Robert P. Ragusa, MBA |
Corporate headquarters Sunnyvale, California |
.
